Outcomes of Experiencing Interpersonal Violence in Autism: A Mixed Methods Systematic Review and Meta-Analysis.

Trauma Violence AbuseAug 9, 2025 (epub)
Clinical ResearchPsychiatryPediatrics

Kassandrah Cooke, Kathryn Ridgway, Laura Pecora et al.

✦ AI-curated · Sources linked

In 30 seconds

This mixed-methods systematic review and meta-analysis examined outcomes of interpersonal violence among autistic people and gender-related differences. The random-effects meta-analysis pooled data from 9 studies involving 3,647 autistic participants aged 1 to 80 years. Violence was associated with worse mental health, with the strongest reported associations for internalizing symptoms (d = 0.66, p < .001; 95% CI [0.51, 0.80]) and suicidal thoughts and behavior (d = 0.63, p < .001; [0.44, 0.82]). Narrative synthesis of 57 studies also linked violence to adverse health, developmental, and functional outcomes, with greater difficulties reported by females and gender minorities.

Key findings

  • Violence was associated with internalizing symptoms (d = 0.66, p < .001; 95% CI [0.51, 0.80]).
  • Violence was associated with suicidal thoughts and behavior (d = 0.63, p < .001; [0.44, 0.82]).
  • Across 57 studies, violence was linked to adverse health, developmental, and functional outcomes, including greater mental health and behavioral difficulties than in non-autistic controls.
  • Females and gender minorities reported greater violence-related health and developmental difficulties, emerging in early childhood and continuing into adulthood.

Why it matters

The review brings together evidence that interpersonal violence is associated with substantial and potentially enduring difficulties for autistic people, including mental health and behavioral outcomes. Its findings also highlight differences by gender, supporting attention to intersecting marginalization when assessing the consequences of violence and interpreting the needs of autistic people across the lifespan.

What to keep in mind

The evidence combines studies with varied methods and outcomes; the meta-analysis pooled data from 9 studies, while broader conclusions rely on narrative synthesis.

Source

Published in Trauma Violence Abuse. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.